What is our Investment Case?

In becoming the trusted global leader in access to medicines, the Group has consistently delivered healthy financial performances and returns. Below are the reasons to invest in Clinigen.

Unique combination of businesses

We offer access to medicines at all stages of the pharmaceutical product lifecycle, utilising operational synergies across the services and products divisions

Global Capability

We have built a global supply chain and distribution network, organically, through acquisitions and partnerships, providing local market knowledge supported by global expertise, supplying into over 100 countries

Market-leading Positions

We are the market-leader in CTS and Unlicensed Medicines

Unparralleled Knowledge and Expertise

We are experts in the supply and distribution of unlicensed medicines

Experienced Management Team

We have an experienced and diverse Group and regional management, with a track record of delivering strong growth every year since inception

Significant Long-Term Growth Potential

The business can grow both through organic growth, with an increasing exposure to emerging pharmaceutical growth markets and through acquisition

Trusted Ethical Supplier

We have deep well-established relationships with pharmaceutical companies
and pharmacists

Highly Cash Generative

We generate strong cash returns which are underpinned by strong credit control and working capital management